Search for: "Simonian v. Allergan, Inc."
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
4 Mar 2011, 2:48 am
Simonian v. [read post]
25 Jan 2012, 3:20 am
Simonian v. [read post]
2 May 2011, 8:35 pm
Allergan, Inc., Judge Amy J. [read post]
2 May 2011, 7:16 am
" Simonian v. [read post]
18 Mar 2010, 2:30 am
Allergan, Inc. [read post]
3 Dec 2010, 5:53 am
" Simonian v. [read post]
16 May 2011, 11:51 am
”The April 28 opinion in Simonian v. [read post]
16 Jun 2010, 3:02 pm
(Patent Docket) US: False marking plaintiff borrows a page from Simonian in filing its own amended complaint: Simonian v. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
8 Dec 2010, 2:20 am
PTO (Holman’s Biotech IP Blog) US: District Court N D Illinois: False marking intent to deceive may be alleged generally under FRCP 9(b), regardless of the deceived ‘public’s’ sophistication: Simonian v. [read post]
